# Landiolol in Postoperative Atrial Fibrillation

> **NCT03779178** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 58 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Landiolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03779178
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-17
- **Primary completion:** 2019-12-04
- **Final completion:** 2019-12-04
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779178, "Landiolol in Postoperative Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03779178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*